Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Jan has led and held board roles in more than 25 investments across six funds including notable exits with HandyLab (acquired by BD), Esperion (Nasdaq: ESPR), NxThera (acquired by Boston Scientific), CardioMEMS
0
By: 0
"0"
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

However, if you would like to share the information in this article, you may use the link below:
endoscopy.medicaltechoutlook.com/cxo-awards/top-10-medtech-vcs-2024/jan-garfinkle/
